[Evaluation of the usefulness of analysis of beta-glucuronidase levels in patients with superficial cancer and papilloma of the bladder].
Beta-glucuronidase activity in the blood serum, the urine, and tumour tissue has been assayed in patients with superficial bladder neoplasm and papilloma of the bladder prior to and after transurethral electroresection (TUR). Twenty five healthy subjects constituted a control group. It was shown that the activity of beta-glucuronidase may be a valuable test in the differential diagnosis of bladder neoplastic lesions as well as in the assessment of the results of therapy with transurethral electroresection.
Rokicki
M
M
II Katedry i Kliniki Urologii w Zabrzu Sl. AM, Katowicach.
Rokicki
W
W
Paradysz
A
A
Fryczkowski
M
M
D000328:Adult; D000368:Aged; D015415:Biomarkers; D002278:Carcinoma in Situ / Q000201:enzymology* / Q000601:surgery; D002291:Carcinoma, Papillary / Q000201:enzymology* / Q000601:surgery; D015653:Cystectomy; D004598:Electrosurgery; D004789:Enzyme Activation / Q000502:physiology; D005966:Glucuronidase / Q000097:blood / Q000378:metabolism* / Q000652:urine; D006801:Humans; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D001743:Urinary Bladder / Q000201:enzymology; D001749:Urinary Bladder Neoplasms / Q000201:enzymology* / Q000601:surgery
D015415:Biomarkers; D005966:Glucuronidase
Ocena przydatności oznaczania beta-glukuronidazy u chorych na raka i brodawczaka pecherza moczowego.